Shangpharma Corp Stock Current Asset
ShangPharma Corp fundamentals help investors to digest information that contributes to ShangPharma Corp's financial success or failures. It also enables traders to predict the movement of ShangPharma Stock. The fundamental analysis module provides a way to measure ShangPharma Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ShangPharma Corp stock.
ShangPharma |
ShangPharma Corp Company Current Asset Analysis
ShangPharma Corp's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current ShangPharma Corp Current Asset | 72.35 M |
Most of ShangPharma Corp's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ShangPharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, ShangPharma Corp has a Current Asset of 72.35 M. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The current asset for all United States stocks is notably lower than that of the firm.
ShangPharma Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ShangPharma Corp's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ShangPharma Corp could also be used in its relative valuation, which is a method of valuing ShangPharma Corp by comparing valuation metrics of similar companies.ShangPharma Corp is currently under evaluation in current asset category among its peers.
ShangPharma Fundamentals
Return On Asset | 0.02 | |||
Profit Margin | 0.05 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 86.32 M | |||
Shares Outstanding | 335.54 M | |||
Number Of Shares Shorted | 17.53 K | |||
Price To Earning | 48.93 X | |||
Price To Book | 1.16 X | |||
Price To Sales | 1.29 X | |||
Revenue | 111.6 M | |||
Gross Profit | 36.1 M | |||
EBITDA | 22.78 M | |||
Net Income | 11.11 M | |||
Cash And Equivalents | 40.34 M | |||
Cash Per Share | 1.85 X | |||
Total Debt | 754.98 K | |||
Debt To Equity | 0.26 % | |||
Current Ratio | 2.78 X | |||
Cash Flow From Operations | 18.28 M | |||
Short Ratio | 0.20 X | |||
Earnings Per Share | 0.18 X | |||
Price To Earnings To Growth | 1.33 X | |||
Number Of Employees | 2.08 K | |||
Beta | 1.43 | |||
Market Capitalization | 135.41 M | |||
Total Asset | 166.9 M | |||
Retained Earnings | 33.01 M | |||
Working Capital | 41.6 M | |||
Current Asset | 72.35 M | |||
Current Liabilities | 30.74 M |
Pair Trading with ShangPharma Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ShangPharma Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ShangPharma Corp will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Hess could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hess when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hess - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hess Corporation to buy it.
The correlation of Hess is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hess moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hess moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hess can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in ShangPharma Stock
If you are still planning to invest in ShangPharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ShangPharma Corp's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |